GANX Gains 20.13%
Wed, Sep 08, 2021 at 05:30 PM
GANX (GANX:NASDAQ) jumped higher at $9.49, a gain of 20.1%. On Tue, Sep 07, 2021, GANX:NASDAQ hit a New 2-Week Intraday High of $8. The stock appeared on our News Catalysts scanner on Wed, Sep 08, 2021 at 10:39 AM in the 'BIOTECH' category. From Tue, Aug 24, 2021, the stock recorded 44.44% Up Days and 50.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About GANX (GANX:NASDAQ)
Gain Therapeutics Inc is a development-stage biotechnology company developing novel therapeutics to treat diseases caused by protein misfolding, with an initial focus on lysosomal storage disorders...
Top 10 Gainers:
- EFTR (EFTR:NASDAQ), 111.77%
- LWAC (LWAC:NASDAQ), 92.95%
- HLBZ (HLBZ:NASDAQ), 84.02%
- Kadmon Holdings, Inc. (KDMN:NASDAQ), 71.13%
- Globalstar, Inc. (GSAT:NYSEMKT), 29.95%
- ATER (ATER:NASDAQ), 29.35%
- LGL Systems Acquisition Corp. (DFNS:NYSE), 26.85%
- ICU Medical, Inc. (ICUI:NASDAQ), 26.23%
- ARQQ (ARQQ:NASDAQ), 23.98%
- GANX (GANX:NASDAQ), 20.13%